Tranexamic Acid and the Risk of Delirium after Off-Pump Surgery

Thorac Cardiovasc Surg. 2024 Jan;72(1):51-54. doi: 10.1055/s-0042-1745811. Epub 2022 Jun 6.

Abstract

We investigated whether in patients undergoing off-pump coronary artery bypass grafting surgery a single bolus of 1 g tranexamic acid (TXA) impacts the risk of postoperative delirium using the propensity score matching approach. In 2,757 pairs, the risk of delirium was 4.2% (TXA group) and 5.0% (non-TXA group), with a relative risk in the TXA versus the non-TXA group of 0.83 (95% confidence interval: 0.65-1.07; p = 0.16). There was no significant interaction between TXA administration and renal function on the risk of delirium (p = 0.12). Data indicate that a single bolus of 1 g TXA does not increase the risk of delirium in patients undergoing off-pump surgery.

MeSH terms

  • Antifibrinolytic Agents* / adverse effects
  • Coronary Artery Bypass, Off-Pump* / adverse effects
  • Delirium* / diagnosis
  • Delirium* / etiology
  • Delirium* / prevention & control
  • Humans
  • Tranexamic Acid* / adverse effects
  • Treatment Outcome

Substances

  • Tranexamic Acid
  • Antifibrinolytic Agents